Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3

MONDO:0956997

An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as grade 3 tumors associated with a more rapid growth. Grade 3 tumors appear to have abnormalities on chromosomes 9 or 10, along with unusual amounts of growth factors and proteins, which are thought to contribute to the more rapid growth of these gliomas.

2822 clinical trials for this condition and its sub-types, 2 tagged with Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ IDH-mutant and 1p/19q-codeleted oligodendroglioma (13)

Including sub-types (2822) Tagged with Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3 (2)

Not yet recruiting 1 Not yet finished but already full! 1

New hope for deadly brain cancer? early trial launches

Disease control Not yet recruiting

This early-stage study tests a new drug called FZ-AD005 in 40 people with aggressive brain tumors (high-grade glioma) that have come back or not responded to treatment. The drug is designed to target and kill cancer cells while sparing healthy ones. The main goals are to find the…

Phase 1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:11 UTC

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3

Where it sits in the disease tree

New hope for deadly brain cancer? early trial launches